New York University researchers say a simple, gene-based blood test has shown to be highly accurate in predicting whether ...

A new study led by the University of Oxford has revealed that a common and usually harmless virus may positively influence ...

The team is optimizing the cancer genome analysis system to integrate it into CRC diagnosis and tailor treatments based on ...

A new research perspective was published in Oncotarget, Volume 16, on April 4, 2025, titled “GSK3β activation is a key driver of resistance to Raf inhibition in BRAF mutant melanoma cells.” ...

Additionally, NRX-0305, a BRAF degrader, showed broad efficacy across all three mutation classes of BRAF, with significant anti-tumor activity in resistant tumors. The company is also developing ...

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer ...

Side effects include skin rash and diarrhea. BRAF gene change. Two of the main drugs used for this one are dabrafenib (Tafinlar) and trametinib (Mekinist). They work in different ways, but both ...

BRAF gene fusions are much more common than BRAF V600 mutations – accounting for more than half of all cases, according to Ipsen – and there are currently no approved targeted treatments for ...

Anaplastic thyroid cancer (ATC), a rare yet highly aggressive malignancy, continues to represent a major clinical challenge.

Colorectal cancer (CRC), a type of cancer that affects the large intestine and rectum, is one of the leading causes of cancer-related deaths worldwide.